Inventiva IVA
NASDAQ IVA
$3.56 -0.13 (-3.52%)
As of: Oct 1, 2026 · 2:01 PM EDT

Inventiva (IVA) Cash from Operations (2020 - 2026)

Updated

Inventiva's Cash from Operations came in at -$52.82 million for Q2 2026, compared with -$60.81 million a year earlier.

Analysis

Inventiva (IVA) Cash from Operations (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Inventiva reported Cash from Operations of -$180.15 million; for FY2025, it was -$122.09 million.

  • Going back by year, Cash from Operations was -$91.82 million in FY2024, -$87.81 million in FY2023, -$45.84 million in FY2022 and -$56.36 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Cash from Operations since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 8.62 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.44 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.58 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.57 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.13 Bn
10 Inventiva 713.04 Mn 713.04 Mn - -52.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -52.82 Mn
Jun 30, 2025 121.63 Mn
Jun 30, 2024 -52.06 Mn
Jun 30, 2021 -14.46 Mn
Mar 31, 2021 -9.39 Mn
Jun 30, 2020 -3.96 Mn
Mar 31, 2020 -3.95 Mn
API Access

Inventiva Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=IVA&period=max&api_key=YOUR_API_KEY